Last reviewed · How we verify

NCT04495738

Infant Formula and Toddler Drink Feeding Intervention

Terminated NA Last updated 14 May 2021
What this trial tests

NA trial testing Control Infant Formula in Respiratory Infections in Children in 168 participants. Terminated before completion.

Timeline
10 August 2020
Primary endpoint
12 April 2021
12 April 2021

Quick facts

Lead sponsorAbbott Nutrition
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeother
Enrollment168
Start date10 August 2020
Primary completion12 April 2021
Estimated completion12 April 2021
Sites27 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Abbott Nutrition — full company profile →

Who can join

Under 14 Days, any sex, with Respiratory Infections in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized, multi-center, controlled, double-blind, parallel study is to evaluate the health and developmental outcomes of children fed a new infant formula and toddler drink through 24 months of age.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Control Infant Formula

Trials testing the same drug.

Other Abbott Nutrition trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04495738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing